Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Ovarian Neoplasms 12Small Cell Lung Carcinoma 11Fallopian Tube Neoplasms 9Neuroblastoma 6Neoplasm Metastasis 3Lung Neoplasms 3Ganglioneuroblastoma 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Sarcoma, Ewing 2Rhabdoid Tumor 2Recurrence 2Leukemia, Myeloid, Acute 2Glioma 2Central Nervous System Neoplasms 2Wilms Tumor 1Thrombocythemia, Essential 1SCLC 1Primary Myelofibrosis 1Polycythemia Vera 1Pleuropulmonary blastoma 1Peritoneal Neoplasms 1Pediatric Brain Tumor 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

Cyclophosphamide 26fludarabine 18Dexamethasone 17pembrolizumab 12Rituximab 11Etoposide 10venetoclax 9pomalidomide 9Gemcitabine 9fludarabine phosphate 7daratumumab 7Lenalidomide 7Bortezomib 7carfilzomib 6obinutuzumab 5glofitamab 5Vincristine 5Temozolomide 5Prednisone 5Nivolumab 5Immunotherapy, Adoptive 5Cisplatin 5Calcium Dobesilate 5selinexor 4cemiplimab 4Doxorubicin 4Cytarabine 4Carboplatin 4zanubrutinib 3ruxolitinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Topotecan × 90 days × Clear all
NCT03154996 2026-04-22

Chronic Convection Enhanced Delivery of Topotecan

Columbia University

Phase 1 Completed
5 enrolled
CNS

Glioma, Recurrence

NCT02298348 2026-03-23

N2013-02

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Active not recruiting
18 enrolled
CNS

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡